CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biotechnology company developing novel therapeutics for neurological diseases, announced today that their first ...

A genetically engineered mouse initially designed to explore muscle repair mechanisms instead helped University of Iowa scientists understand how a certain type of calcium channel helps coronary ...

Phase II trial of triple-receptor tyrosine kinase receptor inhibitor nintedanib (BIBF 1120) in recurrent high-grade gliomas. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ulixacaltamide HCl for the treatment of essential tremor in adults. Ulixacaltamid ...

Work at Praxis Precision Medicines Inc. has led to the identification of new compounds comprising an azaspiroheptane and acting as T-type calcium channel blockers, particularly voltage-dependent ...